A look at the science and clinical results of a novel, super-oxidized antiseptic solution in the treatment of wounds

Two years ago I brought before this Society what I thought to be strong arguments in favour of the substitution of cotton wool impregnated with a non-volatile antiseptic for the carbolic gauze commonly in use in the treatment of recent wounds. A year ago I related also to this Society a series of experiments which led me to believe that the spray of carbolic acid was useful only in so far as it...

This article highlights a neglected feature of Joseph Lister's work, namely how, in addition to promoting germ theories and the principles of the antiseptic system, he also devoted much time and effort to communicating the performative aspects of antisepsis and of the many other surgical innovations that he developed. Attention to 'detail' and striving for 'improvement' were crucial to Listeria...

Antimicrobials are classified by the pathogens targeted, e.g. as antibacterials or antifungals. This grouping may be subdivided as antibacterials also include urinary antiseptics and anti-mycobacterial drugs. Antimicrobials, especially antibacterials, are strictly classified into chemotherapeutic agents (synthetic chemicals), and antibiotics, produced from living organisms, usually fungi. Howev...

Despite recent research advances in anti-infective agents (achievements), Human immunodeficiency virus (HIV), and malaria infection are currently considered two main global human health problems. Given the considerable geographical overlap between malaria and HIV, a substantial number of co-infection incidences occur in human. The purpose of this review is to summarize the information on the cl...

Most drugs are currently developed, approved and marketed based on their effect the majority of population [...]

The global burden of antibiotic resistance is tremendous and, without new anti-infective strategies, will continue to increase in the coming decades. Despite the growing need for new antibiotics, few pharmaceutical companies today retain active antibacterial drug discovery programmes. One reason is that it is scientifically challenging to discover new antibiotics that are active against the ant...